腹膜透析和血液透析对尿毒症患者血清BNP的影响(2)
![]() |
第1页 |
参见附件。
参考文献:
[1]van Kimmenade RR,Januzzi JL Jr,Bakker JA,et al.renal clearance of B-type natriuretic peptide and aminoterminal pro-Btype natriuretic Peptide a mechanistic studyin hypertensive subjects[J],JAmCollCandiol,2009,53(10):884-890
[2]proBNP,fluidvolume overload anddialysis modality are independent predictors of mortality in ESRD patient Paniagua R1, Ventura MD, Avila-Díaz M[J],Nephrol Dial Transplant,2010 ,25(2):551-557.
[3]Zoecali C,Mallamaci F,Benedetto FA,et a1.Cardiac natriuretic Peptide are related to left ventricular mass and function and predict mortality in dialysis patients[J].J Am Soc Nephrol,2001,12(7):1508-1515.
[4]刘婧,孙倩美.脑钠肽与慢性肾脏病患者心血管疾病关系的研究进展[J].中国血液净化,2008,7(1):38-41.
[5]陈胜芳,崔春黎,马骏,等. 血清NT-pro-BNP水平与腹膜透析患者营养状况和残余肾功能及透析充分性的关系[J].同济大学学报,2012,33(4).
[6]姜林森,石永兵,沈华英.腹膜透析和血液透析患者心脏负荷的临床分析[J].中国血液流变学杂志,2009,19(2):249.
[7]Sanjuan R, Oliva SM, Blasco ML,et al. Plasma Brain Natriuretic Peptide Levels in Cardiac Function Assessment in Chronic Dialysis Patients[J],Cardiorenal Med,2011,1(3): 147-155.
编辑/哈涛
您现在查看是摘要介绍页,详见PDF附件。